Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT04061135
- Status
- Recruiting
Conditions
- Movement Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Response Inhibition and Deep Brain Stimulation in Parkinson's disease — PROCEDUREAfter creation of the burr hole and prior to DBS electrode placement, 1-2 subdural strip electrodes will be placed anteriorly or posteriorly from the cranial opening. These electrodes are routinely placed using this technique for seizure mapping, with arrays of electrodes (up to 6) being placed around the perimeter of the opening.14 Subdural strips vary in length and contact size (e.g., the 6-contact Ad-Tech strip), and are currently placed predominantly for studies of sensorimotor function,13 including at our institution (IRB-140327003). Placement over prefrontal areas is performed at other institutions.11-13 The DBS surgery will then proceed according to routine practice, and following lead placement in the optimal desired location, the research task paradigm will begin.
Study Details
The purpose of this study is to investigate the brain activity associated with motor and non-motor symptoms of movement disorders, including Parkinson's disease (PD) and essential tremor. These movement disorders commonly have significant non-motor features, such as depression, cognitive and memory impairment, decreased attention, speech and language disturbances, and slower processing speeds. The investigators are interested in the brain activity associated with these motor and non-motor symptoms, and propose to investigate changes in brain activity while the investigators perform recordings of the surface and deep structures of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.
Key Dates
- Start date
- Sep 1, 2019
- Status verified
- Mar 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TreatmentParkinson's Disease Patients receiving DBS electrodes
- No Intervention: ControlControl subjects will be non-Parkinson's Disease patients with essential tremor
Primary Outcome Measure
Accuracy via Simon Task (% correct) [ Time Frame: Baseline ]
Central Contacts
- Nicole Bentley, MD205-975-0011
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 |
Find similar trials in Birmingham, AL
Related Studies
- Botulinum Toxin for the Treatment of Involuntary Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- SLC13A5 Deficiency Natural History Study - Remote OnlyEnrolling By Invitation · TESS Research Foundation · Palo Alto, California
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home MeasuresRecruiting · Target ALS Foundation, Inc. · Phoenix, Arizona